WHO Chief shared all the information he shared for the children, the second Malaria Vaccine in the world


Malaria cases have increased rapidly in the last several decades worldwide. In such a situation, another new vaccine for children has been removed by the World Health Organization itself.

Not only in India, there has been a rapid increase in cases of malaria worldwide. In such a situation, this news from the World Health Organization is very relieving. Indeed, the World Health Organization has agreed to a new vaccine (new malaria vaccine) for the prevention of malaria in children. The name of this vaccine is R21 / Matrix-M. Earlier in the year 2021, RTS, S / AS01 came. This vaccine has been developed by Oxford University in the UK. The special thing is that the R21 / Matrix-M vaccine has been manufactured by the Serum Institute of India and is already called Burkina Faso, Approval was granted for use in Ghana and Nigeria.

We have another safe and effective vaccine against malaria: WHO Chief Tedros Adhanom Ghebreyesus
Strategic Advisory Group of Experts on Immunization ( Strategic Advisory Group of Experts on Immunization-SAGE) and Malaria Policy Advisory Group ( Malaria Policy Advisory Group-MPAG) and regular biennials held on 25–29 September It was only after the meeting that the WHO Director-General showed it green. During this time the World Health Organization ( WHO) also shared a lot of information from people, while recommending this vaccine for the prevention of malaria in children.

During this time, WHO chief Tedros Adnom Ghebius said, “As a malaria researcher, I used to dream of the day when we would have a safe and effective vaccine against malaria. Now we have two.” Not only this, the WHO Chief also said that earlier the demand for the RTS, S vaccine was more than the supply, Therefore this second vaccine will serve as an urgent additional tool to protect more children faster and bring us closer to our vision of a malaria-free future.

The -R21 vaccine may be helpful in reducing the transmission of malaria by 75.

  1. The vaccine showed 66% effectiveness during the 12 months following the first 3 doses.
  2. A year later the fourth dose also showed effectiveness in the prevention of malaria.

Explain that the WHO has also issued recommendations for new vaccines for dengue and meningitis on the advice of SAGE. The WHO has also issued several recommendations regarding the polio vaccination program.

Leave a Reply

Your email address will not be published. Required fields are marked *

Voting Poll
[democracy id="1"]
%d bloggers like this: